Spyre Therapeutics (SYRE) files mixed shelf
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/24/2026
- Wall Street closes lower to end rocky week
- Meta's capital-raising plans expose a major weakness in the AI boom
- Oil prices jump $3 on Houthi attacks, oil spill, highest settlement since April
- BofA flags further downside risk for stocks, yields and dollar
- SpaceX cell-site ambitions lift tower stocks and weigh on carriers
Form S-3 Spyre Therapeutics, Inc.
February 19, 2026 4:34 PM ESTAs filed with the Securities and Exchange Commission on February 19, 2026. Registration No.... More



